MedPath

Timely Reperfusion in Acute ST-segment Myocardial Infarction

Completed
Conditions
Acute Myocardial Infarction
Registration Number
NCT04614805
Lead Sponsor
University Hospital of North Norway
Brief Summary

The aim of the study is to monitor outcomes, especially time to reperfusion, in ST-elevation acute myocardial infarction patients.

Detailed Description

In the regional health trust of North Norway, time to reperfusion in acute ST-elevation myocardial infarction is below the national average and below recommendations. The aim of this study is to monitor outcomes, especially time to reperfusion, in ST-elevation acute myocardial infarction patients. The study period is supposedly lasting for approximately 4 months, the time estimated to observe the clinical course of 100 patients. Before and during the study period, clinical leaders are encouraged to improve guideline adherence and to closely monitor the results of their own and collaborating institutions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
146
Inclusion Criteria
  • Patient diagnosed with acute myocardial infarction with ST-elevations within our regional health trust during Nov 1st and for approx 4 months, and with an indication for reperfusion therapy (thrombolysis and/pr PCI)
Exclusion Criteria
  • Reperfusion therapy not indicated or contraindicated

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to reperfusionThis parameter will be recorded within 1 week after patient inclusion

Interval between 1st medical contact and opening of the infarction-related coronary artery.

Secondary Outcome Measures
NameTimeMethod
Ejection fraction at dischargeThis parameter will be recorded up to 6 months after patient inclusion

Systolic function of the left ventricle

SurvivalThis parameter will be collected from patient's records during Nov -20 till Aug -21.

Survival after 30 days from incident

Trial Locations

Locations (1)

University Hospital North Norway

🇳🇴

Tromsø, Troms Og Finnmark, Norway

© Copyright 2025. All Rights Reserved by MedPath